LDHA and acute myeloid leukemia: Although HSC and LSC can, in a considerable part of AML cases, be distinguished using aberrancies of marker expression [12]–[14] and scatter properties [5], [16], assessment of ALDH activity enables such discrimination in all AML cases even in the absence of aberrancies.